The Continuing Evolution of Precision Health in Type 2 Diabetes

Achievements and Challenges

Yuan Lin, Jennifer Wessel

Research output: Contribution to journalReview article

Abstract

Purpose of Review: The purpose of this review was to summarize recent advances in the genomics of type 2 diabetes (T2D) and to highlight current initiatives to advance precision health. Recent Findings: Generation of multi-omic data to measure each of the “biologic layers,” developments in describing genomic function and annotation in T2D relevant tissue, along with the increasing recognition that T2D is a heterogeneous disease, and large-scale collaborations have all contributed to advancing our understanding of the molecular basis of T2D. Summary: Substantial advances have been made in understanding the molecular basis of T2D pathogenesis, such that precision health diabetes is increasingly becoming a reality. For precision diabetes to become a routine in clinical and public health, additional large-scale multi-omic initiatives are needed along with better assessment of our environment to delineate an individual’s diabetes subtype for improved detection and management.

Original languageEnglish (US)
Article number16
JournalCurrent Diabetes Reports
Volume19
Issue number4
DOIs
StatePublished - Apr 1 2019

Fingerprint

Type 2 Diabetes Mellitus
Health
Genomics
Public Health

Keywords

  • Genetics
  • Genomics
  • Heterogeneity
  • Precision diabetes
  • Review
  • Type 2 diabetes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

The Continuing Evolution of Precision Health in Type 2 Diabetes : Achievements and Challenges. / Lin, Yuan; Wessel, Jennifer.

In: Current Diabetes Reports, Vol. 19, No. 4, 16, 01.04.2019.

Research output: Contribution to journalReview article

@article{2754cf1c3219450c9dd6601038cc0ad5,
title = "The Continuing Evolution of Precision Health in Type 2 Diabetes: Achievements and Challenges",
abstract = "Purpose of Review: The purpose of this review was to summarize recent advances in the genomics of type 2 diabetes (T2D) and to highlight current initiatives to advance precision health. Recent Findings: Generation of multi-omic data to measure each of the “biologic layers,” developments in describing genomic function and annotation in T2D relevant tissue, along with the increasing recognition that T2D is a heterogeneous disease, and large-scale collaborations have all contributed to advancing our understanding of the molecular basis of T2D. Summary: Substantial advances have been made in understanding the molecular basis of T2D pathogenesis, such that precision health diabetes is increasingly becoming a reality. For precision diabetes to become a routine in clinical and public health, additional large-scale multi-omic initiatives are needed along with better assessment of our environment to delineate an individual’s diabetes subtype for improved detection and management.",
keywords = "Genetics, Genomics, Heterogeneity, Precision diabetes, Review, Type 2 diabetes",
author = "Yuan Lin and Jennifer Wessel",
year = "2019",
month = "4",
day = "1",
doi = "10.1007/s11892-019-1137-2",
language = "English (US)",
volume = "19",
journal = "Current Diabetes Reports",
issn = "1534-4827",
publisher = "Current Medicine Group",
number = "4",

}

TY - JOUR

T1 - The Continuing Evolution of Precision Health in Type 2 Diabetes

T2 - Achievements and Challenges

AU - Lin, Yuan

AU - Wessel, Jennifer

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Purpose of Review: The purpose of this review was to summarize recent advances in the genomics of type 2 diabetes (T2D) and to highlight current initiatives to advance precision health. Recent Findings: Generation of multi-omic data to measure each of the “biologic layers,” developments in describing genomic function and annotation in T2D relevant tissue, along with the increasing recognition that T2D is a heterogeneous disease, and large-scale collaborations have all contributed to advancing our understanding of the molecular basis of T2D. Summary: Substantial advances have been made in understanding the molecular basis of T2D pathogenesis, such that precision health diabetes is increasingly becoming a reality. For precision diabetes to become a routine in clinical and public health, additional large-scale multi-omic initiatives are needed along with better assessment of our environment to delineate an individual’s diabetes subtype for improved detection and management.

AB - Purpose of Review: The purpose of this review was to summarize recent advances in the genomics of type 2 diabetes (T2D) and to highlight current initiatives to advance precision health. Recent Findings: Generation of multi-omic data to measure each of the “biologic layers,” developments in describing genomic function and annotation in T2D relevant tissue, along with the increasing recognition that T2D is a heterogeneous disease, and large-scale collaborations have all contributed to advancing our understanding of the molecular basis of T2D. Summary: Substantial advances have been made in understanding the molecular basis of T2D pathogenesis, such that precision health diabetes is increasingly becoming a reality. For precision diabetes to become a routine in clinical and public health, additional large-scale multi-omic initiatives are needed along with better assessment of our environment to delineate an individual’s diabetes subtype for improved detection and management.

KW - Genetics

KW - Genomics

KW - Heterogeneity

KW - Precision diabetes

KW - Review

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85062156201&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062156201&partnerID=8YFLogxK

U2 - 10.1007/s11892-019-1137-2

DO - 10.1007/s11892-019-1137-2

M3 - Review article

VL - 19

JO - Current Diabetes Reports

JF - Current Diabetes Reports

SN - 1534-4827

IS - 4

M1 - 16

ER -